Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours

Auteurs

Didier Frappaz, Sara M. Federico, Andrew D.J. Pearson, Lia Gore, Margaret E. Macy, Steven G. DuBois, Isabelle Aerts, Robert Iannone, Ryan Geschwindt, Arne Van Schanke, Rui Wang, Birgit Geoerger